EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Tailored Adherence Incentives for Childhood Asthma Medications

Chén C Kenyon, William O Quarshie, Rui Xiao, Mishaal Yazdani, Carina M Flaherty, G Chandler Floyd, Victoria A Miller, Tyra C Bryant-Stephens, Joseph J Zorc, Chris Feudtner

JAMA Pediatrics · 01.05.2025 · 179 (5) · 500

DOI: 10.1001/jamapediatrics.2025.0010 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA Pediatrics, erschienen am 01.05.2025. Verfasst von Chén C Kenyon und 9 weiteren Autor:innen. Beteiligte Einrichtung: PolicyLab, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Anti-Asthmatic Agents, Asthma, Medication Adherence, Motivation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Differential adherence to efficacious preventive medications is one potentially modifiable driver of racial disparities in childhood asthma outcomes.

Objective

To determine the effect of a financial incentive-enhanced intervention on adherence to inhaled asthma preventive medication in a high-risk, predominantly racially minoritized cohort of children with asthma. Design, Setting, and Participants This was a randomized clinical trial conducted from September 2019 through June 2022 at a large mid–Atlantic pediatric health system in the US. Children were eligible if they were between 5 and 12 years old, prescribed a preventive inhaler for daily use, and had at least 2 asthma exacerbations requiring systemic steroids in the preceding year. Data were analyzed from December 2022 to December 2024.

Intervention

Inhaled medication use was monitored using electronic inhaler sensors over a 7-month period. Families who completed a 1-month run-in interval were randomized to 1 of 3 arms for a 3-month experiment interval: (1) daily text message medication reminders, weekly adherence feedback, and gain-framed, financial incentives of up to $1 per day (full intervention); (2) daily text message medication reminders and weekly adherence feedback (hybrid intervention); or (3) no reminders, feedback, or incentives (active control). Medication adherence monitoring then continued for a 3-month observation interval, where all arms reverted to active control conditions. Main Outcomes and Measures The primary outcome was adherence to inhaled maintenance medication during the experiment; secondary outcomes included adherence during the observation phase. The study was powered to detect a difference in average monthly adherence between the full intervention and active control condition.

Results

Of the 106 children randomized, 99 had at least 1 month of monitoring data (56 male [57%] and 43 female [43%]; mean [SD] age, 8.0 [2.3] years). Most participants (81 [82%]) identified as non-Hispanic Black and demographic and clinical characteristics were similar across study arms. During the experiment interval, participants receiving the full intervention had a 15–percentage point (95% CI, 2-29 percentage points) higher inhaled maintenance medication adherence compared with participants in the active control. There was no evidence of adherence differences in the observation interval. Conclusion and Relevance While a financial incentive-enhanced mobile health intervention led to higher inhaled preventive medication adherence as compared with the active control group, there was no evidence for enduring effect after the intervention components ceased, consistent with other studies that include financial incentives to encourage behavior change. Trial Registration ClinicalTrials.gov Identifier: NCT03907410

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Asthmatic AgentsAsthmaMedication AdherenceMotivationChildChild, PreschoolFemaleHumansMaleAdministration, InhalationReminder SystemsText Messaging

Substanzen

Anti-Asthmatic Agents

Autor:innen und Institutionen

  • PolicyLab, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Division of General Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • University of Pennsylvania Perelman School of Medicine, Philadelphia.
  • Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Department of Medicine, New York University Grossman School of Medicine, New York City.
  • Division of Adolescent Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Kenyon, C. C., Quarshie, W. O., Xiao, R., Yazdani, M., Flaherty, C. M., Floyd, G. C., Miller, V. A., Bryant-Stephens, T. C., Zorc, J. J., & Feudtner, C. (2025). Tailored Adherence Incentives for Childhood Asthma Medications. JAMA Pediatrics, 179(5), 500. https://doi.org/10.1001/jamapediatrics.2025.0010

Vancouver

Kenyon CC, Quarshie WO, Xiao R, Yazdani M, Flaherty CM, Floyd GC, et al. Tailored Adherence Incentives for Childhood Asthma Medications. JAMA Pediatrics. 2025;179(5):500. doi:10.1001/jamapediatrics.2025.0010

BibTeX
@article{Kenyon2025,
  author = {Kenyon, Chén C and Quarshie, William O and Xiao, Rui and Yazdani, Mishaal and Flaherty, Carina M and Floyd, G Chandler and Miller, Victoria A and Bryant-Stephens, Tyra C and Zorc, Joseph J and Feudtner, Chris},
  title = {Tailored Adherence Incentives for Childhood Asthma Medications},
  journal = {JAMA Pediatrics},
  year = {2025},
  volume = {179},
  number = {5},
  pages = {500},
  doi = {10.1001/jamapediatrics.2025.0010}
}
Kostenlos starten →